Corum Group Capital Raise
Corum Group was up by more than 20% after affirming its push to capitalize on growth opportunities within the pharmacy software and adjacent markets. The company has consequently raised $3.66 million on a fully subscribed placement of 146.4 million ordinary shares. The capital raise drive saw Alchemy Healthcare invest $1.5 million.
With the new finances, the company remains well-positioned to come up with the next generation cloud-enabled solutions as it also continues to deliver innovative and value-enhancing solutions. The capital raise drive comes just days after the company confirmed completion of negotiations on the development of a number of solutions with BAMM Administration
The two are joining forces to come up with software solutions that will assist in multi-store management and in-store retail operations within the pharmacy industry in Australia. The agreement paves the way for Corum to accelerate the project as it moves to strengthen its intellectual property.
With the new finances, the company remains well-positioned to come up with the next generation cloud-enabled solutions as it also continues to deliver innovative and value-enhancing solutions. The capital raise drive comes just days after the company confirmed completion of negotiations on the development of a number of solutions with BAMM Administration
The two are joining forces to come up with software solutions that will assist in multi-store management and in-store retail operations within the pharmacy industry in Australia. The agreement paves the way for Corum to accelerate the project as it moves to strengthen its intellectual property.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.